Single dose GLP-1-Tf ameliorates myocardial ischemia/reperfusion injury. - Wikidata - wikimedia - TriplyDB

Single dose GLP-1-Tf ameliorates myocardial ischemia/reperfusion injury.

Single dose GLP-1-Tf ameliorates myocardial ischemia/reperfusion injury.

http://www.wikidata.org/entity/Q33925948

about

Incretin-Based Therapy for Prevention of Diabetic Vascular Complications Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters GLP-1 and cardioprotection: from bench to bedside Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas.Epac is required for GLP-1R-mediated inhibition of oxidative stress and apoptosis in cardiomyocytes Cardiovascular and hemodynamic effects of glucagon-like peptide-1.Transferrin fusion technology: a novel approach to prolonging biological half-life of insulinotropic peptides Selective targeting of glucagon-like peptide-1 signalling as a novel therapeutic approach for cardiovascular disease in diabetes A meta-analysis of the therapeutic effects of glucagon-like Peptide-1 agonist in heart failure.Cardiovascular biology of the incretin system.Impaired cardiometabolic responses to glucagon-like peptide 1 in obesity and type 2 diabetes mellitus Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control.The potential effects of anti-diabetic medications on myocardial ischemia-reperfusion injury.Cardiovascular effects of incretin-based therapies.Cardioprotective effects of incretin during ischaemia-reperfusion.GLP-1 receptor agonists: effects on cardiovascular risk reduction.Impact of glucagon-like peptide-1 on myocardial glucose metabolism revisited.Phosphodiesterase-3 inhibition augments the myocardial infarct size-limiting effects of exenatide in mice with type 2 diabetes.Postconditioning with glucagon like peptide-2 reduces ischemia/reperfusion injury in isolated rat hearts: role of survival kinases and mitochondrial KATP channels.[Cardiovascular effects of incretin-based therapies].Effects of glucagon-like peptide 1 analogs in combination with insulin on myocardial infarct size in rats with type 2 diabetes mellitus

P2860

Q26765470-86E595B1-4F59-4A35-B5EF-D4BDCAFBFA97 Q26801319-0DFB6B67-6AF8-4DAC-AAC7-60121BB1D0F1 Q27024984-28C3D436-8E53-4F74-A761-CC1B3C4FAA63 Q33603384-59E339F8-A885-4C9F-85D7-215946798F24 Q33631733-849B4C16-406A-484D-A991-E88A8C6AE1F9 Q33993725-C1646815-BBAC-44CF-954E-41AA412814CB Q34128861-C9A606C4-48BA-46A9-AE92-0667BF0A748C Q34994502-F3FF385A-4A7F-4C00-A87D-EB2744214BCE Q36090588-C13D94CB-FFE4-468C-9312-7ACED99CC928 Q36484283-53AE3B3E-519D-4A79-A25E-08AF09E0A289 Q37065219-62932289-96E5-4B93-A8FD-943EC628104F Q37825946-CE658081-BAD6-4F5E-840A-41AE40A475FB Q37926558-1FD44853-325A-4F83-BD45-73835C1B2B88 Q37977336-32E957DD-6001-4A92-B88E-7F60D4BA3933 Q38002006-643969CA-1C01-46F6-80A1-6372A8E9ACFB Q38122396-5F7D9F57-8E6F-4035-B16A-730273768714 Q38218639-BF19D4AB-7F1C-4753-BCC5-81CEECF15EA3 Q47275749-45182FD2-AD2D-4C58-9F09-34718D571B70 Q47620961-2EBF2CD1-FA3C-43C7-8314-2020B7176ADF Q54522495-5828BE4E-AA67-4A83-8370-5BF98BC1A3AA Q58737185-F3E0F383-174F-4A02-8640-E3D57AE10FCF

P2860

Single dose GLP-1-Tf ameliorates myocardial ischemia/reperfusion injury.

http://www.wikidata.org/entity/Q33925948

description

2009 nî lūn-bûn

@nan

2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Single dose GLP-1-Tf ameliorates myocardial ischemia/reperfusion injury.

@ast

Single dose GLP-1-Tf ameliorates myocardial ischemia/reperfusion injury.

@en

type

label

Single dose GLP-1-Tf ameliorates myocardial ischemia/reperfusion injury.

@ast

Single dose GLP-1-Tf ameliorates myocardial ischemia/reperfusion injury.

@en

prefLabel

Single dose GLP-1-Tf ameliorates myocardial ischemia/reperfusion injury.

@ast

Single dose GLP-1-Tf ameliorates myocardial ischemia/reperfusion injury.

@en

P1433

Q33925948-F40965FD-0C15-4C7B-AAC0-98696B7EF122

P1476

Q33925948-69725180-F1E3-49B6-B35E-A5784C53B787

P2093

Q33925948-2527DF04-966A-4715-8331-3B9032829ABD

Q33925948-2D8C7101-167B-4415-9B8E-0D870A55A6F6

Q33925948-30A04274-0F29-42E9-8947-9B42615BB40D

Q33925948-9D09C3F1-3AA3-49D9-AA5E-651D5773F9EE

Q33925948-A67A4072-D1A5-4D9C-A139-5AAEBB211612

Q33925948-C1AE884C-C4C7-4408-ADB0-E62DD0DACF0B

Q33925948-F9B0F823-93D2-49B3-963D-1CFDD393F938

P2860

Q33925948-01C92303-8A97-4DAF-876B-F3AC0C733A03

Q33925948-11984EE8-0F91-4551-B4F5-2E99543EB5FD

Q33925948-28CD1718-E519-489B-953C-0A90DBA9D5CC

Q33925948-2977B934-DFCB-4D52-B831-9DAFB80DBAFD

Q33925948-2CD915E9-A87F-40DA-A142-0E21707DB7EE

Q33925948-2E0B4028-B23B-4E53-AA63-4BB1A446AD70

Q33925948-38A977E3-AB3B-4D12-A384-C442DD75F47A

Q33925948-436A67A8-041D-4293-8BEC-3CB9F5D92445

Q33925948-47E25313-9722-4238-AC7C-1A8808526470

Q33925948-481CD56B-2005-4750-9CA4-EFB9DE236F10

P304

Q33925948-F8199D50-AF07-4966-84B9-302E5E5DB79B

P31

Q33925948-36DE15F6-8897-4BA3-B1DB-9B56A458B07F

P356

Q33925948-81F5ED7A-D88E-446F-A790-1BADF0C550FC

P433

Q33925948-103BADE7-30C6-4B00-BAF9-8E6F926873C6

P478

Q33925948-5233BDB4-E34D-4967-BFB9-8C08A9D5F017

P50

Q33925948-723852A0-8A4F-4459-9394-5FA65F77D393

P577

Q33925948-292C60F4-51C4-4FF6-9CBF-4FFE03C5C69E

P5875

Q33925948-3287113F-7B51-47C0-9916-287781E7392A

P698

Q33925948-3047419C-D2F7-4577-8E17-9378DDDDC04E

P921

Q33925948-5B8AD7F6-3A7E-4912-A261-518FFD922872

P932

Q33925948-4CF8B938-3143-4565-B679-DB0D92BA7FE0

P356

J.JSS.2009.03.016

P1433

Journal of Surgical Research

P1476

Single dose GLP-1-Tf ameliorates myocardial ischemia/reperfusion injury.

@en

P2093

Earl F Albone

http://www.w3.org/2001/XMLSchema#string

Joseph H Gorman

http://www.w3.org/2001/XMLSchema#string

Muneaki Matsubara

http://www.w3.org/2001/XMLSchema#string

Robert C Gorman

http://www.w3.org/2001/XMLSchema#string

Robin Hinmon

http://www.w3.org/2001/XMLSchema#string

Shinya Kanemoto

http://www.w3.org/2001/XMLSchema#string

Theodore Plappert

http://www.w3.org/2001/XMLSchema#string

P2860

Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C

Myocardial reperfusion: a double-edged sword?

Low-pressure reperfusion alters mitochondrial permeability transition

Tissue-specific expression of the human receptor for glucagon-like peptide-I: brain, heart and pancreatic forms have the same deduced amino acid sequences

Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis

Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons

Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal

New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway.

Insulin therapy as an adjunct to reperfusion after acute coronary ischemia: a proposed direct myocardial cell survival effect independent of metabolic modulation.

GLP-1 inhibition of pancreatic islet cell apoptosis.

P304

38-45

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JSS.2009.03.016

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

165

http://www.w3.org/2001/XMLSchema#string

P50

Bradley G Leshnower

P577

2009-04-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26317322

http://www.w3.org/2001/XMLSchema#string

P698

19552923

http://www.w3.org/2001/XMLSchema#string

P921

reperfusion injury

P932

2888810

http://www.w3.org/2001/XMLSchema#string